Cargando…

Diagnostic Value of the Neutrophil/Lymphocyte Ratio, Platelet/Lymphocyte Ratio, and Thrombocytosis in the Preoperative Investigation of Ovarian Masses

Objective To evaluate the diagnostic accuracy of cancer antigen 125 (CA125) and complete blood count (CBC) parameters, such as the neutrophil to lymphocyte ratio (NLR), the platelet to lymphocyte ratio (PLR), and thrombocytosis in patients with ovarian masses. Methods The present is a retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshida, Adriana, Sarian, Luís Otavio, Marangoni, Marcos, Firmano, Isis Caroline, Derchain, Sophie Françoise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Revinter Publicações Ltda 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10309221/
https://www.ncbi.nlm.nih.gov/pubmed/32559800
http://dx.doi.org/10.1055/s-0040-1712991
_version_ 1785066403832791040
author Yoshida, Adriana
Sarian, Luís Otavio
Marangoni, Marcos
Firmano, Isis Caroline
Derchain, Sophie Françoise
author_facet Yoshida, Adriana
Sarian, Luís Otavio
Marangoni, Marcos
Firmano, Isis Caroline
Derchain, Sophie Françoise
author_sort Yoshida, Adriana
collection PubMed
description Objective To evaluate the diagnostic accuracy of cancer antigen 125 (CA125) and complete blood count (CBC) parameters, such as the neutrophil to lymphocyte ratio (NLR), the platelet to lymphocyte ratio (PLR), and thrombocytosis in patients with ovarian masses. Methods The present is a retrospective study conducted at a single tertiary hospital from January 2010 to November 2016. We included consecutive women referred due to suspicious adnexal masses. The CBC and CA125 were measured in the serum of 528 women with ovarian masses before surgery or biopsy. We evaluated the diagnostic performance of the NLR, PLR, platelets (PLTs), CA125, and the associations between them. We tested the clinical utility of the CBC parameters and CA125 in the discrimination of ovarian masses through decision curve analysis (DCA). Results The best balance between sensitivity and specificity was obtained by the associations of CA125 or PLTs ≥ 350/nL, with 70.14% and 71.66%, CA125 or PLTs ≥ 400/nL, with 67.30% and 81.79%, CA125 or PLR, with 76.3% and 64.87%, and CA125 or NLR, with 71.09% and 73.89% respectively. In the DCA, no isolated CBC parameter presented a higher clinical utility than CA125 alone. Conclusion We showed that no CBC parameter was superior to CA125 in the prediction of the malignancy of ovarian tumors in the preoperative scenario.
format Online
Article
Text
id pubmed-10309221
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Thieme Revinter Publicações Ltda
record_format MEDLINE/PubMed
spelling pubmed-103092212023-07-27 Diagnostic Value of the Neutrophil/Lymphocyte Ratio, Platelet/Lymphocyte Ratio, and Thrombocytosis in the Preoperative Investigation of Ovarian Masses Yoshida, Adriana Sarian, Luís Otavio Marangoni, Marcos Firmano, Isis Caroline Derchain, Sophie Françoise Rev Bras Ginecol Obstet Objective To evaluate the diagnostic accuracy of cancer antigen 125 (CA125) and complete blood count (CBC) parameters, such as the neutrophil to lymphocyte ratio (NLR), the platelet to lymphocyte ratio (PLR), and thrombocytosis in patients with ovarian masses. Methods The present is a retrospective study conducted at a single tertiary hospital from January 2010 to November 2016. We included consecutive women referred due to suspicious adnexal masses. The CBC and CA125 were measured in the serum of 528 women with ovarian masses before surgery or biopsy. We evaluated the diagnostic performance of the NLR, PLR, platelets (PLTs), CA125, and the associations between them. We tested the clinical utility of the CBC parameters and CA125 in the discrimination of ovarian masses through decision curve analysis (DCA). Results The best balance between sensitivity and specificity was obtained by the associations of CA125 or PLTs ≥ 350/nL, with 70.14% and 71.66%, CA125 or PLTs ≥ 400/nL, with 67.30% and 81.79%, CA125 or PLR, with 76.3% and 64.87%, and CA125 or NLR, with 71.09% and 73.89% respectively. In the DCA, no isolated CBC parameter presented a higher clinical utility than CA125 alone. Conclusion We showed that no CBC parameter was superior to CA125 in the prediction of the malignancy of ovarian tumors in the preoperative scenario. Thieme Revinter Publicações Ltda 2020-06-19 2020-07 /pmc/articles/PMC10309221/ /pubmed/32559800 http://dx.doi.org/10.1055/s-0040-1712991 Text en https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Yoshida, Adriana
Sarian, Luís Otavio
Marangoni, Marcos
Firmano, Isis Caroline
Derchain, Sophie Françoise
Diagnostic Value of the Neutrophil/Lymphocyte Ratio, Platelet/Lymphocyte Ratio, and Thrombocytosis in the Preoperative Investigation of Ovarian Masses
title Diagnostic Value of the Neutrophil/Lymphocyte Ratio, Platelet/Lymphocyte Ratio, and Thrombocytosis in the Preoperative Investigation of Ovarian Masses
title_full Diagnostic Value of the Neutrophil/Lymphocyte Ratio, Platelet/Lymphocyte Ratio, and Thrombocytosis in the Preoperative Investigation of Ovarian Masses
title_fullStr Diagnostic Value of the Neutrophil/Lymphocyte Ratio, Platelet/Lymphocyte Ratio, and Thrombocytosis in the Preoperative Investigation of Ovarian Masses
title_full_unstemmed Diagnostic Value of the Neutrophil/Lymphocyte Ratio, Platelet/Lymphocyte Ratio, and Thrombocytosis in the Preoperative Investigation of Ovarian Masses
title_short Diagnostic Value of the Neutrophil/Lymphocyte Ratio, Platelet/Lymphocyte Ratio, and Thrombocytosis in the Preoperative Investigation of Ovarian Masses
title_sort diagnostic value of the neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and thrombocytosis in the preoperative investigation of ovarian masses
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10309221/
https://www.ncbi.nlm.nih.gov/pubmed/32559800
http://dx.doi.org/10.1055/s-0040-1712991
work_keys_str_mv AT yoshidaadriana diagnosticvalueoftheneutrophillymphocyteratioplateletlymphocyteratioandthrombocytosisinthepreoperativeinvestigationofovarianmasses
AT sarianluisotavio diagnosticvalueoftheneutrophillymphocyteratioplateletlymphocyteratioandthrombocytosisinthepreoperativeinvestigationofovarianmasses
AT marangonimarcos diagnosticvalueoftheneutrophillymphocyteratioplateletlymphocyteratioandthrombocytosisinthepreoperativeinvestigationofovarianmasses
AT firmanoisiscaroline diagnosticvalueoftheneutrophillymphocyteratioplateletlymphocyteratioandthrombocytosisinthepreoperativeinvestigationofovarianmasses
AT derchainsophiefrancoise diagnosticvalueoftheneutrophillymphocyteratioplateletlymphocyteratioandthrombocytosisinthepreoperativeinvestigationofovarianmasses